期刊文献+

膈俞穴注射川芎嗪治疗冠心病临床研究 被引量:8

Clinical Experimental Study on Treatment of Coronary Heart Disease with Injection of Ligustrazine into Geshu Point(BL 17)
暂未订购
导出
摘要 本文对100例患者分别进行了穴位注射药液及穴位电针刺激,比较观察了其对血浆6-酮-前列腺素F1α(6-K-P)含量、血栓素B2(TXB2)含量和6-K-P/TXB2比值的影响。结果一疗程后,膈俞川芎嗪组、膈俞生理盐水组、膈俞电针组、肺俞川芎嗪组均能调节血浆6-K-P、血浆TXB2及6-K-P/TXB2比值(P<0.01,P<0.001),肺俞电针组无此作用(P>0.05)。进一步的分析表明,有效组间的疗效亦有一定的差异。 Effects of acupoint injection and electroacupuncture stimulation on plasma contents of 6-ketoprostaglandin F1α (6-K-P),thromboxane B2(TXB2) and 6-K-P/TXB2 ratio were compared in 100 cases of coronary heart disease. Results showed that after one therapeutic course,plasma contents of 6-K-P and TXB2 and 6-K-P/TXB2 ratio were regulated to varying degrees in Geshu-ligustrazine group,Geshu-saline group, Geshu-electroacupuncture group,Feshu(BL 13)-ligustrazine group.While there was not the effect in Feishu-electroacupuncture group. Among them,the Geshu-ligustrazine group had the best therapeutic effects.The effects are exerted possibly by regulating prostacyclin-thromboxane A2 system.
出处 《中国针灸》 CAS CSCD 北大核心 1996年第6期3-5,共3页 Chinese Acupuncture & Moxibustion
关键词 冠状动脉疾病 川芎嗪 隔俞穴注射 冠心病 CORONARY DISEASE/acupoint ther TETRAMETHYL PYRAZINE/admin POINT BL 17(GESHU)
  • 相关文献

参考文献4

二级参考文献5

共引文献24

同被引文献140

引证文献8

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部